Chinook Therapeutics
Randy Anderson, MS, is a seasoned professional in quality compliance within the biopharmaceutical and regulatory sectors, currently serving as Senior Director of Quality Compliance at Chinook Therapeutics, Inc. since July 2022. With prior leadership roles at Instil Bio and MEI Pharma, Randy has extensive experience overseeing global quality compliance programs and managing GMP inspection readiness. A former Investigator with the US Food & Drug Administration, Randy managed quality systems and coordinated multi-office operations. Additionally, Randy has military experience as a Captain in the United States Army Reserve, overseeing deployment health assessments. Educational qualifications include a Master's in Regulatory Science and Medical Product Quality from the University of Southern California and a Bachelor's in Microbiology from Iowa State University, with ongoing doctoral studies in Engineering Management at Capitol Technology University.
This person is not in any teams
This person is not in any offices
Chinook Therapeutics
Chinook is a clinical-stage biopharmaceutical company discovering, developing and commercializing precision medicines for rare, severe chronic kidney diseases.